Mahamaya Lifesciences IPO Timeline
The Mahamaya Lifesciences IPO is a book build issue with a total issue size of ₹70.44 cr, comprising of fresh issue of 5329200 equity shares. , and a offer for sale of 540000 equity shares.
Mahamaya Lifesciences IPO opened for subscription on Nov 11, 2025 and closed on Nov 13, 2025. The basis of allotment got finalized on Nov 14, 2025, and listed on both the NSE and BSE on Nov 18, 2025.
*Info is indicative. Not an Investment Advice. Grey market trading is unregulated.
Mahamaya Lifesciences IPO Timeline (Tentative)
- IPO Open Date
- Tuesday, 11 November 2025
- IPO Close Date
- Thursday, 13 November 2025
- Basis of Allotment
- Friday, 14 November 2025
- Initiation of Refunds
- Monday, 17 November 2025
- Credit of Shares to Demat
- Monday, 17 November 2025
- Listing Date
- Tuesday, 18 November 2025 — NSE & BSE
Important Dates
Open Date
11 November 2025
Close Date
13 November 2025
Basis Of Allotment
14 November 2025
Listing Date
18 November 2025
Disclaimer: This data is for informational purposes only and does not constitute investment advice. Figures shown are illustrative sample data.
Frequently Asked Questions
Everything you need to know before applying to an IPO.
Mahamaya Lifesciences IPO is a Book-building IPO with a total issue size of ₹70.44 crore. The Mahamaya Lifesciences IPO price band is ₹108 to 114 per share. The Mahamaya Lifesciences IPO subscription opens on Tue, Nov 11, 2025, and closes on Thu, Nov 13, 2025. The Mahamaya Lifesciences IPO will be listed on the BSE. Kfin Technologies Limited is the registrar for the Mahamaya Lifesciences IPO.
The Mahamaya Lifesciences IPO opens on Tue, Nov 11, 2025 and closes on Thu, Nov 13, 2025
Mahamaya Lifesciences IPO Price Band is ₹108 to 114 per share.
Mahamaya Lifesciences IPO lot size is 1200 shares, Retail investors need a minimum investment of ₹273600 based on the upper price band
The minimum investment for Mahamaya Lifesciences IPO is ₹273600, based on one lot of 1200 shares at the upper price band of ₹114 per share.
Investors can apply for the Mahamaya Lifesciences IPO through the ASBA (Application Supported by Blocked Amount) facility offered by their bank or through UPI using a SEBI-registered broker or trading app. Select the desired lot size, enter your bid within the price band, and submit the application before Thu, Nov 13, 2025. The application amount remains blocked until the Mahamaya Lifesciences IPO allotment is finalized.
Mahamaya Lifesciences IPO issue size is ₹70.44 crores.
Mahamaya Lifesciences IPO allotment date is Wed, Jul 1, 2026.
The registrar for Mahamaya Lifesciences IPO is Kfin Technologies Limited. Investors can go to Kfin Technologies Limited website to check Mahamaya Lifesciences IPO allotment status, refund processing, and other IPO-related information.